<DOC>
	<DOCNO>NCT00002284</DOCNO>
	<brief_summary>To determine whether zidovudine ( AZT ) conjunction bone marrow transplantation prevents reinfection donor hematopoietic/lymphoid cell patient positive HTLV III antibody large cell/diffuse histiocytic lymphoma . Patients candidate evaluate HTLV III activity drug level .</brief_summary>
	<brief_title>A Study Azidothymidine ( AZT ) Treatment HIV Infection Patients Receiving Bone Marrow Transplant</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition : Patients current lifethreatening infection time transplant would preclude transplant exclude . Concurrent Medication : Excluded : Other antiretroviral agent . Patients current lifethreatening infection time transplant would preclude transplant exclude . Patients must : HTLV III antibody positive ELISA Western blot HTLV III viremia . At high mortal risk diagnosis AIDS AIDS Related Complex ( ARC ) . Also patient must fall one follow category : Have HIV seronegative identical twin serve bone marrow donor . Have documentation large cell/diffuse histiocytic lymphoma/DPDL . Be good risk candidate bone marrow transplant .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 1995</verification_date>
	<keyword>Lymphoma , Large-Cell</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Bone Marrow Transplantation</keyword>
</DOC>